http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0977558-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 1997-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fb82354f170ed7f3cf80304eb7fcc6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185c24187716b1ebc6c0918067151847
publicationDate 2003-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0977558-B1
titleOfInvention Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
abstract PCT No. PCT/EP97/00586 Sec. 371 Date Aug. 11, 1998 Sec. 102(e) Date Aug. 11, 1998 PCT Filed Feb. 7, 1997 PCT Pub. No. WO97/29739 PCT Pub. Date Aug. 21, 1997The present invention concerns the use of receptor antagonists of the 5HT4 receptor for avoiding, alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors. The present invention also concerns pharmaceutical formulations comprising 5HT4-receptor antagonists for alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors, as well as pharmaceutical compositions comprising 5HT4 receptor antagonists and serotonin reuptake inhibitors.
priorityDate 1996-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129626560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5324346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54359408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129178651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57287256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226486745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129471329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232787712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127407860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129892280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136254025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136263326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228944491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228944489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128328645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53426308
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128942828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129385211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135953052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135853223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774

Total number of triples: 89.